176 -4 (78) 2025 - Artikova S.G., Haydarova N.B. - STUDY OF CARDIOVASCULAR STATUS IN FATTY LIVER DISEASE ASSOCIATED WITH METABOLIC DYSFUNCTION

STUDY OF CARDIOVASCULAR STATUS IN FATTY LIVER DISEASE ASSOCIATED WITH METABOLIC DYSFUNCTION

A.A. Mavlonov - Andijan State Medical Institute

Haydarova N.B. - Andijan State Medical Institute

Dauletbaev B.K. - Andijan State Medical Institute

Avazbekov B.A. - Andijan State Medical Institute

Resume

Metabolic fatty liver dysfunction (MFLD) is currently one of the leading diseases of the organs. The main triggers for its development are poor nutrition, physical inactivity, and excess body weight. The process of diagnosing MFLD involves complex laboratory and instrumental studies. The highest criterion for a reliable assessment is liver biopsy, the "gold standard", but its limited use is due to the invasiveness of the method, which makes it relevant to use it mainly for differentiating MFLD from other liver pathologies. This paper discusses the mechanisms of development MFLD and, diagnostic criteria, and current directions for therapy MFLD, including the use of ademetionine.

Key words: liver steatosis, steatohepatitis, metformin, pioglitazone, glucagon-like peptide-1 agonists, essential phospholipids.

First page

987

Last page

989

For citation:Artikova S.G., Haydarova N.B., Dauletbaev B.K., Avazbekov B.A. - STUDY OF CARDIOVASCULAR STATUS IN FATTY LIVER DISEASE ASSOCIATED WITH METABOLIC DYSFUNCTION//New Day in Medicine 4(78)2025 987-989 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

1. Баланова Ю.А., Капустина А.В., Драпкина О.М. Поведенческие факторы риска в российской популяции: результаты обследования по модифицированной методологии STEPS // Профилактическая медицина. 2020. Т. 23. № 5. С. 56–66.
2. Дедов И.И., Шестакова М.В., Мельниченко Г.А., Шереметьева Е.В. Междисциплинарные клинические рекомендации «лечение ожирения и коморбидных заболеваний» // Ожирение и метаболизм. 2021. Т. 18. № 1. С. 5-99.
3. Артериальная гипертензия у взрослых. Клинические рекомендации 2020 // Российский кардиологический журнал. 2020. Т. 25. № 3. С. 149-218. DOI: 10.15829/1560-4071-2020-3-3786.
4. Неалкогольная жировая болезнь печени у взрослых: клиника, диагностика, лечение. Рекомендации для терапевтов, третья версия // Экспериментальная и клиническая гастроэнтерология. 2021. Т. 185. № 1. С. 4-52.
5. Stefan N. Metabolically Healthy and Unhealthy Normal Weight and Obesity // Endocrinol Metab. 2020. Vol. 35. Is. 3. P. 487-493.

   file

   download